Little York, NJ, United States of America

Kevin J Kapples

This inventor holds 47 USPTO granted patents, plus 1 CIPO patent, primarily in Pharmaceutical Chemistry. Top assignees: Hoechst Roussel Pharmaceuticals, Hoechst Marion Roussel, Frommer Lawrence & Huag LLP. Active years: 1986-2001.


% Patents Active = 100.0

 

Average Co-Inventor Count = 2.7

ph-index = 6

Forward Citations = 114(Granted Patents)


Location History:

  • Warren, NJ (US) (1986 - 1987)
  • Bridgewater, NJ (US) (1987 - 1993)
  • Little York, NJ (US) (1989 - 2001)

Company Filing History:


Years Active: 1986-2001

Loading Chart...
Loading Chart...
Areas of Expertise:
Serotonin Reuptake Inhibitors
Tetrahydroacridines
Heterocyclic Compounds
Isoxazolobenzoxazepines
Pyridinamines
Indoles
Amino Derivatives
Pharmaceutical Compositions
Pyrrolidine
Bicycloalkylidene
Hexahydro Compounds
Antihypertensive Agents
47 patents (USPTO):Explore Patents

Title: The Innovative Mind of Kevin J Kapples

Introduction: Kevin J Kapples, a talented inventor hailing from Little York, NJ (US), is known for his groundbreaking contributions to the world of technology and innovation.

Latest Patents: Kevin J Kapples has recently been granted patents for his cutting-edge inventions in the fields of artificial intelligence and renewable energy technologies.

Career Highlights: Throughout his illustrious career, Kevin J Kapples has consistently pushed the boundaries of what is possible, revolutionizing industries with his forward-thinking ideas and inventive solutions.

Collaborations: Kevin J Kapples has collaborated with leading research institutions and tech companies to bring his visionary concepts to life, showcasing his ability to work effectively in multidisciplinary teams.

Conclusion: In conclusion, Kevin J Kapples stands as a true pioneer in the world of innovation, with a proven track record of transforming ideas into tangible, impactful inventions that have the potential to shape the future of technology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…